Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 53
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 2601 | WOTA | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2602 | XAMPLA | 6 | 00% | 0 | 6 | 2023–2025 |
| 2603 | XIAOMI EV TECHNOLOGY | 6 | 00% | 0 | 6 | 2023–2025 |
| 2604 | XTEND AI | 6 | 116.7% | 1 | 4 | 2023–2026 |
| 2605 | XUXIN TECHNOLOGY SHENZHEN GROUP | 6 | 00% | 0 | 6 | 2024–2025 |
| 2606 | YASA | 6 | 00% | 1 | 5 | 2022–2025 |
| 2607 | YNSECT | 6 | 116.7% | 1 | 4 | 2021–2024 |
| 2608 | ZAP ENERGY | 6 | 00% | 0 | 6 | 2023–2025 |
| 2609 | ZEVRA THERAPEUTICS | 6 | 233.3% | 0 | 4 | 2022–2024 |
| 2610 | ZHEJIANG AUSUN PHARMACEUTICAL | 6 | 116.7% | 1 | 4 | 2022–2025 |
| 2611 | ZHEJIANG BORETECH ENVIRONMENTAL ENGINEERING | 6 | 00% | 0 | 6 | 2023–2024 |
| 2612 | ZHEJIANG DAHUA TECHNOLOGY | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2613 | ZHUHAI ENPOWER ELECTRIC | 6 | 116.7% | 0 | 5 | 2022–2022 |
| 2614 | ZOBELE HOLDING | 6 | 233.3% | 0 | 4 | 2021–2025 |
| 2615 | 1080 NETWORK | 5 | 00% | 0 | 5 | 2024–2024 |
| 2616 | 2MH GLAS | 5 | 00% | 0 | 5 | 2023–2024 |
| 2617 | 3SUN S R L | 5 | 00% | 0 | 5 | 2022–2024 |
| 2618 | A L M HOLDING | 5 | 360% | 0 | 2 | 2011–2026 |
| 2619 | AAC OPTICS SUZHOU | 5 | 00% | 0 | 5 | 2024–2024 |
| 2620 | ABEC | 5 | 240% | 0 | 3 | 2020–2025 |
| 2621 | ABLEVIA BIOTECH | 5 | 00% | 0 | 5 | 2023–2023 |
| 2622 | ABUNDIA BIOMASS TO LIQUIDS | 5 | 00% | 0 | 5 | 2023–2023 |
| 2623 | ACONDICIONAMIENTO TARRASENSE | 5 | 00% | 5 | 0 | 2022–2023 |
| 2624 | ACUITIVE TECHNOLOGIES | 5 | 00% | 0 | 5 | 2023–2026 |
| 2625 | ACURASTEM | 5 | 00% | 0 | 5 | 2024–2025 |
| 2626 | ADAPTIMMUNE | 5 | 00% | 0 | 5 | 2022–2023 |
| 2627 | ADC THERAPEUTICS | 5 | 00% | 1 | 4 | 2022–2026 |
| 2628 | ADOCIA | 5 | 00% | 0 | 5 | 2022–2025 |
| 2629 | ADORX THERAPEUTICS | 5 | 00% | 0 | 5 | 2022–2024 |
| 2630 | AFFIMED | 5 | 00% | 0 | 5 | 2022–2024 |
| 2631 | AGFA | 5 | 00% | 0 | 5 | 2024–2026 |
| 2632 | AGR LITHIUM | 5 | 00% | 0 | 5 | 2024–2025 |
| 2633 | AIC246 KG | 5 | 360% | 1 | 1 | 2022–2022 |
| 2634 | AIRBUS DEFENCE AND SPACE | 5 | 00% | 2 | 3 | 2022–2024 |
| 2635 | AIRBUS OPERATIONS | 5 | 00% | 0 | 5 | 2022–2025 |
| 2636 | AKEBIA THERAPEUTICS | 5 | 00% | 0 | 5 | 2022–2023 |
| 2637 | ALECTOR | 5 | 00% | 2 | 3 | 2022–2025 |
| 2638 | ALFA LAVAL MOATTI | 5 | 120% | 0 | 4 | 2022–2025 |
| 2639 | ALIVECOR | 5 | 00% | 0 | 5 | 2022–2024 |
| 2640 | ALLNEX AUSTRIA | 5 | 00% | 0 | 5 | 2023–2024 |
| 2641 | ALTO NEUROSCIENCE | 5 | 00% | 0 | 5 | 2023–2026 |
| 2642 | ALTSOFT | 5 | 120% | 1 | 3 | 2022–2024 |
| 2643 | AMANO ENZYME | 5 | 00% | 0 | 5 | 2022–2025 |
| 2644 | AMBRX | 5 | 00% | 0 | 5 | 2022–2025 |
| 2645 | AMICOAT AS | 5 | 00% | 0 | 5 | 2023–2026 |
| 2646 | AMICOGEN | 5 | 00% | 0 | 5 | 2022–2023 |
| 2647 | AMO IRELAND | 5 | 00% | 0 | 5 | 2022–2023 |
| 2648 | AMUNIX PHARMACEUTICALS | 5 | 00% | 1 | 4 | 2022–2025 |
| 2649 | ANGEL YEAST | 5 | 00% | 0 | 5 | 2023–2025 |
| 2650 | ANIMA BIOTECH | 5 | 00% | 0 | 5 | 2022–2024 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →